- \n
- C\u00e2ncer de mama: abemaciclibe, ribociclibe, palbociclibe<\/li>\n
- C\u00e2ncer de pulm\u00e3o: alectinibe, esilato de nintedanibe, osimertinibe<\/li>\n
- C\u00e2ncer de rim: cabozantinibe<\/li>\n
- C\u00e2ncer de f\u00edgado: regorafenibe, lenvatinibe<\/li>\n
- Melanoma: cobimetinibe, dabrafenibe em combina\u00e7\u00e3o com trametinibe<\/li>\n
- C\u00e2ncer de pr\u00f3stata: apalutamida, enzalutamida<\/li>\n
- Mieloma: citrato de ixazomibe, lenalidomida<\/li>\n
- S\u00edndrome mielodispl\u00e1sica: lenalidomida<\/li>\n
- Linfoma de c\u00e9lulas do manto: ibrutinibe<\/li>\n
- Leucemia linfoc\u00edtica cr\u00f4nica: ibrutinibe, venetoclax<\/li>\n
- Leucemia mieloide aguda: venetoclax, midostaurina<\/li>\n
- Leucemia mieloide cr\u00f4nica: nilotinibe<\/li>\n<\/ul>\n
Medicamentos imunobiol\u00f3gicos <\/strong><\/p>\n
- \n
- Esclerose m\u00faltipla: alentuzumabe, natalizumabe, ocrelizumabe, betainterferona 1\u00aa, acetato de glatir\u00e2mer<\/li>\n
- Hidradenite supurativa: adalimumabe<\/li>\n
- Asma: omalizumabe, benralizumabe, mepolizumabe<\/li>\n
- Psor\u00edase: etanercepte, guselcumabe, infliximabe, ixequizumabe, secuquinumabe, ustequinumabe<\/li>\n
- Retocolite ulcerativa: golimumabe, vedolizumabe, infliximabe<\/li>\n
- Urtic\u00e1ria cr\u00f4nica: omalizumabe<\/li>\n
- Uve\u00edte: adalimumabe<\/li>\n<\/ul>\n
Outros medicamentos<\/strong><\/p>\n
Doen\u00e7a de Paget (deformidades \u00f3sseas): terapia intravenosa com \u00e1cido zoledr\u00f4nico<\/p>\n
Exames<\/strong><\/p>\n
- \n
- Diagn\u00f3stico de sangramento intestinal: enteroscopia do intestino delgado com c\u00e1psula endosc\u00f3pica<\/li>\n
- Detec\u00e7\u00e3o de tuberculose: ensaio para dosagem da libera\u00e7\u00e3o de interferon gama<\/li>\n
- Detec\u00e7\u00e3o de inflama\u00e7\u00e3o intestinal: calprotectina, dosagem fecal<\/li>\n
- Diagn\u00f3stico de risco de pr\u00e9-ecl\u00e2mpsia: raz\u00e3o do teste sFLT-1\/PLGF<\/li>\n
- Detec\u00e7\u00e3o de c\u00e2ncer de pulm\u00e3o: PD-L1 \u2013 detec\u00e7\u00e3o por t\u00e9cnicas imunohistoqu\u00edmicas<\/li>\n
- Diagn\u00f3stico de leucemia mieloide aguda: FLT3 \u2013 pesquisa de muta\u00e7\u00f5es<\/li>\n<\/ul>\n
Terapias<\/strong><\/p>\n
- \n
- Cora\u00e7\u00e3o: abla\u00e7\u00e3o percut\u00e2nea por corrente de crioabla\u00e7\u00e3o para o tratamento da fibrila\u00e7\u00e3o atrial parox\u00edstica<\/li>\n
- C\u00e2ncer de mama: radioterapia intraoperat\u00f3ria por el\u00e9trons (IOERT)<\/li>\n
- Cicatriza\u00e7\u00e3o de feridas e queimaduras: terapia por press\u00e3o negativa<\/li>\n
- Rins: hemodiafiltra\u00e7\u00e3o online (HDF-OL)<\/li>\n<\/ul>\n
Cirurgias<\/strong><\/p>\n
- \n
- Coluna cervical: artroplastia discal de coluna vertebral<\/li>\n
- H\u00e9rnia de disco lombar: cirurgia endosc\u00f3pica da coluna vertebral<\/li>\n
- Cora\u00e7\u00e3o: implante transcateter de pr\u00f3tese valvar a\u00f3rtica (TAVI)<\/li>\n
- Corre\u00e7\u00e3o de deformidade na mand\u00edbula: osteotomia da mand\u00edbula e\/ou maxilar com aplica\u00e7\u00e3o de osteodistrator<\/li>\n<\/ul>\n
Consulta<\/strong><\/p>\n
Consulta com enfermeiro obstetra ou obstetriz<\/p>\n
Altera\u00e7\u00f5es de diretrizes de utiliza\u00e7\u00e3o (inclus\u00e3o de cobertura)<\/strong><\/p>\n
- \n
- Tomografia de coer\u00eancia \u00f3ptica: amplia cobertura para pacientes com glaucoma<\/li>\n
- Implante de monitor de eventos (looper implant\u00e1vel): amplia cobertura para pacientes p\u00f3s-acidente vascular cerebral ou ataque isqu\u00eamico<\/li>\n
- An\u00e1lise molecular de DNA: inclus\u00e3o do exame de \u201cSequenciamento completo do exoma\u201d para investiga\u00e7\u00e3o de defici\u00eancia intelectual de causa indeterminada e inclus\u00e3o de outras especialidades para a solicita\u00e7\u00e3o do procedimento An\u00e1lise Molecular de DNA<\/li>\n
- Transplante alog\u00eanico de medula \u00f3ssea: alinhamento com as indica\u00e7\u00f5es do Minist\u00e9rio da Sa\u00fade para o transplante de c\u00e9lulas tronco hematopoi\u00e9ticas<\/li>\n<\/ul>\n
Tamb\u00e9m pode interessar:<\/strong><\/p>\n
Quem s\u00e3o os High Users e por que sua empresa deveria estar atenta<\/a><\/p>\n
Sua empresa est\u00e1 atenta ao limbo previdenci\u00e1rio?<\/a><\/p><\/blockquote>\n
<\/p>\n
\n\t\t\t\t\tSiga a It’sSeg no\u00a0LinkedIn<\/a>\u00a0e fique por dentro das novidades do Portal RH!<\/div><\/div>\n[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_3″][et_pb_sidebar admin_label=”Barra Lateral” global_module=”399″ orientation=”left” area=”sidebar-1″ background_layout=”light” remove_border=”on” body_line_height=”1.5em” custom_css_widget=”margin-bottom: 30px !important;” saved_tabs=”all”]
\n[\/et_pb_sidebar][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section admin_label=”Se\u00e7\u00e3o” global_module=”93″ fullwidth=”off” specialty=”off” transparent_background=”off” background_color=”#f9f9f9″ allow_player_pause=”off” inner_shadow=”off” parallax=”off” parallax_method=”off” padding_mobile=”on” make_fullwidth=”off” use_custom_width=”off” width_unit=”on” make_equal=”off” use_custom_gutter=”off” custom_padding=”20px||20px|”][et_pb_row global_parent=”93″ admin_label=”Linha” make_fullwidth=”on” use_custom_width=”off” width_unit=”on” use_custom_gutter=”on” gutter_width=”2″ padding_mobile=”off” allow_player_pause=”off” parallax=”off” parallax_method=”off” make_equal=”off” parallax_1=”off” parallax_method_1=”off” parallax_2=”off” parallax_method_2=”off” parallax_3=”off” parallax_method_3=”off” column_padding_mobile=”on” module_class=”footer” module_id_1=”coluna_1″ module_id_2=”coluna_2″ module_id_3=”coluna_3″ module_id=”footer_1″][et_pb_column type=”1_4″][et_pb_text global_parent=”93″ admin_label=”logo it’sseg” background_layout=”light” text_orientation=”left” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]<\/p>\n![](\"https:\/\/segurosinteligentes.com.br\/oldrh\/_old\/wp-content\/uploads\/logo-seguros-inteligentes.png\")
<\/p>\n[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_2″][et_pb_text global_parent=”93″ admin_label=”copyright” background_layout=”light” text_orientation=”right” text_line_height=”1.5em” use_border_color=”off” border_color=”#ffffff” border_style=”solid” custom_padding=”|||20%” text_font=”Abel||||”]<\/p>\n
PORTAL RH IT\u2019SSEG \u00e9 uma publica\u00e7\u00e3o da It\u2019sSeg Seguros Inteligentes. N\u00e3o \u00e9 permitida a reprodu\u00e7\u00e3o do conte\u00fado, mesmo que parcial, para uso comercial de qualquer natureza. Confira aqui<\/a> nossa pol\u00edtica de privacidade.<\/p>\n
[\/et_pb_text][\/et_pb_column][et_pb_column type=”1_4″][et_pb_text global_parent=”93″ admin_label=”logo portal” background_layout=”light” text_orientation=”right” use_border_color=”off” border_color=”#ffffff” border_style=”solid”]<\/p>\n
![\"logo_portal_footer\"](\"https:\/\/segurosinteligentes.com.br\/oldrh\/_old\/wp-content\/uploads\/portalrh-footer.png\")
<\/p>\n[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row global_parent=”93″ admin_label=”Linha” make_fullwidth=”on” use_custom_width=”off” width_unit=”on” use_custom_gutter=”on” gutter_width=”2″ padding_mobile=”on” allow_player_pause=”off” parallax=”off” parallax_method=”off” make_equal=”off” parallax_1=”off” parallax_method_1=”off” parallax_2=”off” parallax_method_2=”off” parallax_3=”off” parallax_method_3=”off” column_padding_mobile=”on” module_id_2=”coluna_2″ module_id_3=”coluna_3″ module_id=”footer_2″ custom_padding=”||0px|”][et_pb_column type=”4_4″][et_pb_text global_parent=”93″ admin_label=”copyright” background_layout=”light” text_orientation=”center” text_line_height=”1.5em” use_border_color=”off” border_color=”#ffffff” border_style=”solid” text_font=”Abel||||”]<\/p>\n
![\"logo_footer_2\"](\"https:\/\/segurosinteligentes.com.br\/oldrh\/_old\/wp-content\/uploads\/logo-seguros-inteligentes-mobile.png\"){kind=logo}
<\/p>\n